🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsSemaglutide (Ozempic / Wegovy)Semaglutide and joint pain improvement — looking for input Page 4

Semaglutide and joint pain improvement — looking for input

wanda_boise Sat, Aug 16, 2025 at 4:16 PM 44 replies 1,898 viewsPage 4 of 9
DebRD_ATL
Senior Member
1,678
7,890
Feb 2024
Atlanta, GA
Aug 21, 2025 at 4:37 PM#16

From the other side of the consultation, briefly. Take it one variable at a time. Almost every unanswerable question in these threads is unanswerable because three things changed in the same fortnight, and no amount of subsequent argument can untangle them after the fact.

41 14BiostatsBrad, PeptideSynthNJ, Dr.KarenChen and 38 others
Reply Quote Save Share Report
kevin_tulsa
Member
489
2,123
Jun 2024
Tulsa, OK
Aug 21, 2025 at 8:16 PM#17
anders_CPH said:
If you are going to change something, change one thing and give it long enough to express itself.

This answered a question I did not know how to ask. Sending this to two other people who asked me the same thing last week.

42 15Dr.RheumBOS, greg_boulder, quinn_sf and 39 others
Reply Quote Save Share Report
jim_asheville
Member
289
1,234
Aug 2024
Asheville, NC
Aug 21, 2025 at 11:55 PM#18

Clinical perspective, offered as context rather than as advice. The honest answer is that the effect is real, the magnitude is contested, and the individual variation is larger than either. Those three things can all be true at once, and most arguments here are two people holding different parts of that.

43 16NurseAsh_DET, BenResearch_OR, MikeKY_noInsulin and 40 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
bri_stats
Member
789
3,456
May 2024
Seattle, WA
Aug 22, 2025 at 3:34 AM#19
jim_asheville said:
The honest answer is that the effect is real, the magnitude is contested, and the individual variation is larger than either.

This matches mine closely enough to be worth saying so. The dose-response is real but shallow at the top. Across STEP 1 and STEP 4 the gap between 1.7mg and 2.4mg is a couple of percentage points of body weight on average, and the average is carrying a wide spread — plenty of people at 1.7mg sit above the 2.4mg mean. If a dose is working and tolerable, "working" is the relevant variable, not "maximal".

I would rather be corrected than agreed with, if it comes to it.

44 17JessicaM_2024, TomFromTexas, mike.trainer_LA and 41 others
Reply Quote Save Share Report
mike_mod
Moderator
7,234
19,823
Nov 2023
New York
Online
Aug 22, 2025 at 7:13 AM#20

Moderator note: a post naming a supplier has been edited. Discuss suppliers in the review sections, not here.

16 14PurityPaulOR, MaxMetOK, MounjBrad and 13 others
Reply Quote Save Share Report

Similar Threads

STEP 1-5 trials comprehensive summary — efficacy endpoints compiled12 replies
Oral semaglutide 50mg Phase 3 — OASIS program results16 replies
Semaglutide pharmacokinetics — half-life, Tmax, steady state modeling10 replies
Compounded semaglutide stability data — temperature and light sensitivity16 replies
0.25mg → 2.4mg titration: optimal schedule based on clinical data6 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register